Epival and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epival (divalproex sodium) and Lantus (insulin glargine recombinant). Common drug interactions include megacolon among females and diabetes mellitus inadequate control among males.

The phase IV clinical study analyzes what interactions people have when they take Epival and Lantus. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Epival?

Epival has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 1,088 Epival users. Check the latest studies of Epival.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

36 people who take Epival and Lantus together, and have interactions are studied.

Epival and Lantus drug interactions.

What are the common drug interactions of Epival and Lantus, by gender? *:

female:

  1. Megacolon (a very dilated colon)
  2. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  3. Intestinal obstruction
  4. Leukopenia (less number of white blood cells in blood)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. General physical health deterioration (weak health status)
  7. Anxiety
  8. Blood glucose decreased
  9. Diarrhoea
  10. Dizziness

male:

  1. Diabetes mellitus inadequate control
  2. Blood cholesterol increased
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Blood creatine phosphokinase increased
  6. Constipation
  7. Dehydration (dryness resulting from the removal of water)
  8. Diabetic hyperosmolar coma (diabetes coma due to extremely high blood sugar (glucose) levels; extreme lack of water (dehydration))
  9. Hyperglycaemia (high blood sugar)
  10. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)

What are the common drug interactions of Epival and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood cholesterol increased
  2. Blood creatine phosphokinase increased
  3. Constipation
  4. Dehydration (dryness resulting from the removal of water)
  5. Diabetes mellitus inadequate control
  6. Diabetic hyperosmolar coma (diabetes coma due to extremely high blood sugar (glucose) levels; extreme lack of water (dehydration))
  7. Hyperglycaemia (high blood sugar)
  8. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  10. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

50-59:

  1. Megacolon (a very dilated colon)
  2. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  3. Intestinal obstruction
  4. Leukopenia (less number of white blood cells in blood)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. General physical health deterioration (weak health status)
  7. Anxiety
  8. Diarrhoea
  9. Dizziness
  10. Gingival bleeding (bleeding gums)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fall
  3. Orthopnoea (shortness of breath (dyspnea) when lying down)
  4. Pneumonia
  5. Psychotic disorder
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  7. Vomiting
  8. Ankle fracture
  9. Back pain
  10. Blood glucose decreased

What are the existing conditions these people have? *

  1. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 25 people, 69.44%
  2. Osteoporosis (bones weak and more likely to break): 4 people, 11.11%
  3. Type 2 Diabetes: 2 people, 5.56%
  4. Constipation: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Epival and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epival and Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epival:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epival and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium and insulin glargine recombinant (the active ingredients of Epival and Lantus, respectively), and Epival and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: